127 related articles for article (PubMed ID: 12148887)
1. Spontaneous IL-8 production by CD4(+), CD7(+) leukemia cells in erythrodermic Sézary syndrome.
Ogawa F; Shimizu K; Hamasakia Y; Tanaka Y; Katayama I; Yamada Y; Tomonaga M
Leuk Lymphoma; 2002 May; 43(5):1061-6. PubMed ID: 12148887
[TBL] [Abstract][Full Text] [Related]
2. CD7-positive Sézary syndrome with a Th1 cytokine profile.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
4. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome.
Dummer R; Nestle FO; Niederer E; Ludwig E; Laine E; Grundmann H; Grob P; Burg G
Arch Dermatol Res; 1999 Jun; 291(6):307-11. PubMed ID: 10421055
[TBL] [Abstract][Full Text] [Related]
5. A case of Sézary syndrome associated with cutaneous transformation.
Sakai H; Matsuo S; Matsumoto M; Iizuka H
J Dermatol; 1996 Oct; 23(10):697-702. PubMed ID: 8973035
[TBL] [Abstract][Full Text] [Related]
6. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
7. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
8. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
Vonderheid EC; Bigler RD; Kotecha A; Boselli CM; Lessin SR; Bernengo MG; Polansky M
J Invest Dermatol; 2001 Sep; 117(3):654-62. PubMed ID: 11564173
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death.
Rappl G; Abken H; Muche JM; Sterry W; Tilgen W; André S; Kaltner H; Ugurel S; Gabius HJ; Reinhold U
Leukemia; 2002 May; 16(5):840-5. PubMed ID: 11986945
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic identification of Sezary cells in peripheral blood.
Bogen SA; Pelley D; Charif M; McCusker M; Koh H; Foss F; Garifallou M; Arkin C; Zucker-Franklin D
Am J Clin Pathol; 1996 Dec; 106(6):739-48. PubMed ID: 8980349
[TBL] [Abstract][Full Text] [Related]
11. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.
Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R
Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856
[TBL] [Abstract][Full Text] [Related]
12. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
[TBL] [Abstract][Full Text] [Related]
13. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
[TBL] [Abstract][Full Text] [Related]
14. Expression of V beta gene segments by Sezary cells.
Gorochov G; Bachelez H; Cayuela JM; Legac E; Laroche L; Dubertret L; Sigaux F
J Invest Dermatol; 1995 Jul; 105(1):56-61. PubMed ID: 7542297
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
Sentis HJ; Willemze R; Scheffer E
J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
[TBL] [Abstract][Full Text] [Related]
16. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
Seo N; Tokura Y; Matsumoto K; Furukawa F; Takigawa M
Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
[TBL] [Abstract][Full Text] [Related]
17. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 is a growth factor for Sézary lymphoma cells.
Dalloul A; Laroche L; Bagot M; Mossalayi MD; Fourcade C; Thacker DJ; Hogge DE; Merle-Béral H; Debré P; Schmitt C
J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
[TBL] [Abstract][Full Text] [Related]
19. The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome.
Miyashiro D; Souza BCE; Torrealba MP; Manfrere KCG; Sato MN; Sanches JA
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055124
[TBL] [Abstract][Full Text] [Related]
20. Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity.
Balfour EM; Glusac EJ; Heald P; Talley LL; Smoller BR
J Cutan Pathol; 2003 Aug; 30(7):437-42. PubMed ID: 12859741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
